样式: 排序: IF: - GO 导出 标记为已读
-
Pregnancy in Autosomal Dominant Polycystic Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-11-27 Mina Al Sayyab,Arlene Chapman
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder occurring in approximately 1:1000 individuals. ADPKD is characterized by gradual cyst expansion and kidney enlargement and is a slowly progressive disorder where patients typically initiate renal replacement therapy in the sixth decade of life. The vast majority of women with ADPKD become pregnant in
-
Renal Diet Metamorphosis Guest Editorial for Advances in Kidney Disease and Health. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-11-21 Holly Kramer,Shivam Joshi
-
Extrarenal Manifestations: Polycystic Liver Disease and Its Complications. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-11-08 Seif Bugazia,Marie C Hogan
The liver is the commonest site of involvement outside of the kidney in autosomal dominant polycystic kidney disease. Most individuals with polycystic liver disease are asymptomatic and require no therapeutic interventions, but a small number of affected individuals who experience symptomatic polycystic liver disease develop medical complications as a result of massive enlargement of cyst number and
-
Intraoperative Renal Replacement Therapy in Orthotopic Liver Transplantation. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Humberto Bohorquez,Jay L Koyner,Courtney R Jones
Acute kidney injury in patients admitted to the hospital for liver transplantation is common, with up to 80% of pretransplant patients having some form of acute kidney injury. Many of these patients start on dialysis prior to their transplant and have it continued intraoperatively during their surgery. This review discusses the limited existing literature and expert opinion around the indications and
-
Entwined Fates: Decoding the Parallel yet Intersecting Pathways of Liver and Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Prakash S Gudsoorkar,Geetha Maddukuri,Juan Carlos Q Velez
-
Palliative Care in Kidney and Liver Diseases. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Antonio Corona,Mary Dominguez,Serife Eti
The role of palliative care is to recognize patients with advanced illnesses who are at risk for poor outcomes and to alleviate their pain and suffering. Patients with both kidney and liver disease are a very vulnerable population due to the unique pathophysiologic relationship these two organs share, which often leads to an abbreviated life expectancy and a significant symptom burden. These patients
-
Essentials of Liver Transplantation in the Setting of Acute Kidney Injury and Chronic Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Stevan A Gonzalez,Ana Cecilia Farfan Ruiz,Ramez M Ibrahim,Hani M Wadei
Kidney dysfunction is common among liver transplant candidates with decompensated cirrhosis and has a major impact on pre- and post-liver transplant survival. Updated definitions of acute kidney injury and criteria for the diagnosis of hepatorenal syndrome allow for early recognition and intervention, including early initiation of vasoconstrictor therapy for hepatorenal syndrome. The rise of the metabolic
-
Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Purva Sharma,Rani Sawtell,Qiyu Wang,Meghan E Sise
Treatment of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection poses unique challenges in patients with kidney disease. Direct-acting antivirals have been a major breakthrough in eradicating HCV infection, and several pangenotypic regimens are available for patients with chronic kidney disease or end-stage kidney disease requiring dialysis with high cure rates and no need for dose
-
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Jacob Nysather,Eda Kaya,Paul Manka,Prakash Gudsoorkar,Wing-Kin Syn
Nonalcoholic fatty liver disease is a multisystem condition with effects beyond the liver. The identification of chronic kidney disease as an independent mediator of nonalcoholic fatty liver disease or associated entity with shared cardiometabolic risk factors remains controversial and continues to draw scientific interest. With increasing prevalence of nonalcoholic fatty liver disease and lack of
-
Chronic Kidney Disease After Liver Transplantation. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Franco H Cabeza Rivera,Beatrice P Concepcion,Swee-Ling L Levea
Chronic kidney disease among liver transplant recipients is common and associated with an increased mortality risk. Several risk factors and causes for the development of chronic kidney disease have been identified. They can be divided into perioperative factors, such as unresolved acute kidney injury; donor-related factors, such as the use of extended criteria liver allografts; and recipient-related
-
Update on Assessment of Estimated Glomerular Filtration Rate in Patients With Cirrhosis. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-07-01 Connor Griffin,Sumeet K Asrani,Kevin R Regner
Kidney disease is associated with adverse outcomes in patients with cirrhosis including increased post-liver transplantation (LT) mortality. Therefore, diagnosis and staging of kidney disease are critical to timely implementation of treatment and have important implications for transplant eligibility. Serum creatinine (sCr) is a key component of the Model for End-Stage Liver Disease score in LT candidates
-
Autosomal Dominant Polycystic Kidney Disease Therapies on the Horizon. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 Julie Xia Zhou,Vicente E Torres
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of numerous kidney cysts which leads to kidney failure. ADPKD is responsible for approximately 10% of patients with kidney failure. Overwhelming evidence supports that vasopressin and its downstream cyclic adenosine monophosphate signaling promote cystogenesis, and targeting vasopressin 2 receptor with tolvaptan
-
Corrigendum to: Deep Learning for Image Analysis in Kidney Care. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01
-
Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 Fouad T Chebib,Ronald D Perrone
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder characterized by relentless growth of innumerable renal cysts bilaterally, associated with decline in glomerular filtration rate over the course of decades. The burden of ADPKD and its treatment is associated with a significant economic and societal cost. Despite several clinical studies conducted over the past decade, only
-
Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 William Ackley,Neera K Dahl,Meyeon Park
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder and the fourth leading cause of end-stage kidney disease. ADPKD encompasses a wide range of morbidity in addition to chronic kidney disease and end-stage kidney disease, and its pathogenesis remains incompletely understood. Progress in the management of this condition includes the 2018 FDA approval of tolvaptan
-
Biomarkers in Polycystic Kidney Disease: Are We There? Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 Alan S L Yu,Douglas P Landsittel
This article describes the use of prognostic, predictive, and response biomarkers that have been developed for autosomal dominant polycystic kidney disease and their use in clinical care or drug development. We focus on biochemical markers that can be assayed in patients' blood and urine and their association with the outcome of decreased glomerular filtration rate. There have been several studies
-
Autosomal Dominant Polycystic Kidney Disease in Children and Adolescents: Assessing and Managing Risk of Progression. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 Angélique Dachy,Liselotte Van Loo,Djalila Mekahli
The clinical management of autosomal dominant polycystic kidney disease (ADPKD) in adults has shifted from managing complications to delaying disease progression through newly emerging therapies. Regarding pediatric management of the disease, there are still specific hurdles related to the management of children and adolescents with ADPKD and, unlike adults, there are no specific therapies for pediatric
-
Mechanisms of Cyst Development in Polycystic Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 Jiahe Qiu,Gregory G Germino,Luis F Menezes
Autosomal dominant polycystic kidney disease is the most common inherited cause of end-stage kidney disease worldwide. Most cases result from mutation of either of 2 genes, PKD1 and PKD2, which encode proteins that form a probable receptor/channel complex. Studies suggest that a loss of function of the complex below an indeterminate threshold triggers cyst initiation, which ultimately results in dysregulation
-
Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-05-01 Cortney N Steele,Kristen L Nowak
Autosomal dominant polycystic kidney disease is a slowly progressive, lifelong disease characterized by continuous development and enlargement of kidney cysts. Thus, nonpharmacological interventions are crucial in disease management and have the potential for a large clinical impact as standalone interventions or in conjunction with pharmacological therapies. Current potential strategies regarding
-
Physiology of a Forgotten Electrolyte-Magnesium Disorders. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Evan Ray,Krithika Mohan,Syeda Ahmad,Matthias T F Wolf
Magnesium (Mg2+) is the second most common intracellular cation and the fourth most abundant element on earth. However, Mg2+ is a frequently overlooked electrolyte and often not measured in patients. While hypomagnesemia is common in 15% of the general population, hypermagnesemia is typically only found in preeclamptic women after Mg2+ therapy and in patients with ESRD. Mild to moderate hypomagnesemia
-
Breaking the Cycle of Recurrent Calcium Stone Disease. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Deepa A Malieckal,Calyani Ganesan,Denisse Arellano Mendez,Alan C Pao
Calcium stones are common and recurrent in nature, yet few therapeutic tools are available for secondary prevention. Personalized approaches for stone prevention have been informed by 24-hour urine testing to guide dietary and medical interventions. However, current evidence is conflicting about whether an approach guided by 24-hour urine testing is more effective than a generic one. The available
-
Physiology Is Fundamental to Patient Care and Research Advances in Nephrology. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Nirupama Ramkumar,Isabelle Dominique V Tomacruz,Deep Phachu,Matthew A Sparks
-
Targeting Glomerular Hemodynamics for Kidney Protection. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Solomiia Savedchuk,Deep Phachu,Mythri Shankar,Matthew A Sparks,Lisa M Harrison-Bernard
The kidney microcirculation is a unique structure as it is composed to 2 capillary beds in series: the glomerular and peritubular capillaries. The glomerular capillary bed is a high-pressure capillary bed, having a 60 mm Hg to 40 mm Hg pressure gradient, capable of producing an ultrafiltrate of plasma quantified as the glomerular filtration rate (GFR), thereby allowing for waste products to be removed
-
Urinary Ammonium in Clinical Medicine: Direct Measurement and the Urine Anion Gap as a Surrogate Marker During Metabolic Acidosis. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Mohammed Z Rehman,Michal Melamed,Autumn Harris,Mythri Shankar,Robert M Rosa,Daniel Batlle
Ammonium is the most important component of urinary acid excretion, normally accounting for about two-third of net acid excretion. In this article, we discuss urine ammonium not only in the evaluation of metabolic acidosis but also in other clinical conditions such as chronic kidney disease. Different methods to measure urine NH4+ that have been employed over the years are discussed. The enzymatic
-
An Update on Kidney Ammonium Transport Along the Nephron. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Autumn N Harris,Mythri Skankar,Michal Melanmed,Daniel Batlle
Acid-base homeostasis is critical to the maintenance of normal health. The kidneys have a central role in bicarbonate generation, which occurs through the process of net acid excretion. Renal ammonia excretion is the predominant component of renal net acid excretion under basal conditions and in response to acid-base disturbances. Ammonia produced in the kidney is selectively transported into the urine
-
A New Understanding of Potassium's Influence Upon Human Health and Renal Physiology. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 James A McCormick,Joel Topf,Isabelle Dominique Tomacruz,P Richard Grimm
Potassium channels are expressed in virtually all cell types, and their activity is the dominant determinant of cellular membrane potential. As such, potassium flux is a key regulator of many cellular processes including the regulation of action potentials in excitable cells. Subtle changes in extracellular potassium can initiate signaling processes vital for survival (insulin signaling) while more
-
Etiology and Management of Edema: A Review. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Abbal Koirala,Negiin Pourafshar,Arvin Daneshmand,Christopher S Wilcox,Sai Sudha Mannemuddhu,Nayan Arora
The development of peripheral edema can often pose a significant diagnostic and therapeutic challenge for practitioners due to its association with a wide variety of underlying disorders ranging in severity. Updates to the original Starling's principle have provided new mechanistic insights into edema formation. Additionally, contemporary data highlighting the role of hypochloremia in the development
-
Novel Concepts in Nephron Sodium Transport: A Physiological and Clinical Perspective. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Justin P Van Beusecum,Fitra Rianto,Jade Teakell,Valentina Kon,Matthew A Sparks,Ewout J Hoorn,Annet Kirabo,Nirupama Ramkumar
The kidneys play a critical role in maintaining total body sodium (Na+) balance across a wide range of dietary intake, accomplished by a concerted effort involving multiple Na+ transporters along the nephron. Furthermore, nephron Na+ reabsorption and urinary Na+ excretion are closely linked to renal blood flow and glomerular filtration such that perturbations in either of them can modify Na+ transport
-
Salt and Water: A Review of Hypernatremia. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-03-01 Niralee Patel,Dhwanil Patel,Samira S Farouk,Joshua L Rein
Serum sodium disorders are generally a marker of water balance in the body. Thus, hypernatremia is most often caused by an overall deficit of total body water. Other unique circumstances may lead to excess salt, without an impact on the body's total water volume. Hypernatremia is commonly acquired in both the hospital and community. As hypernatremia is associated with increased morbidity and mortality
-
Deep Learning Using Electrocardiograms in Patients on Maintenance Dialysis. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-01-01 Zhong Zheng,Qandeel H Soomro,David M Charytan
Cardiovascular morbidity and mortality occur with an extraordinarily high incidence in the hemodialysis-dependent end-stage kidney disease population. There is a clear need to improve identification of those individuals at the highest risk of cardiovascular complications in order to better target them for preventative therapies. Twelve-lead electrocardiograms are ubiquitous and use inexpensive technology
-
Omics and Artificial Intelligence in Kidney Diseases. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-01-01 Nadja Grobe,Josef Scheiber,Hanjie Zhang,Christian Garbe,Xiaoling Wang
Omics applications in nephrology may have relevance in the future to improve clinical care of kidney disease patients. In a short term, patients will benefit from specific measurement and computational analyses around biomarkers identified at various omics-levels. In mid term and long term, these approaches will need to be integrated into a holistic representation of the kidney and all its influencing
-
Review of Artificial Intelligence-Based Signal Processing in Dialysis: Challenges for Machine-Embedded and Complementary Applications. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-01-01 Lena Scherer,Matthias Kuss,Werner Nahm
Artificial intelligence technology is trending in nearly every medical area. It offers the possibility for improving analytics, therapy outcome, and user experience during therapy. In dialysis, the application of artificial intelligence as a therapy-individualization tool is led more by start-ups than consolidated players, and innovation in dialysis seems comparably stagnant. Factors such as technical
-
Federated Learning in Health care Using Structured Medical Data. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-01-01 Wonsuk Oh,Girish N Nadkarni
The success of machine learning-based studies is largely subjected to accessing a large amount of data. However, accessing such data is typically not feasible within a single health system/hospital. Although multicenter studies are the most effective way to access a vast amount of data, sharing data outside the institutes involves legal, business, and technical challenges. Federated learning (FL) is
-
Machine Learning Case Study: Patterns of Kidney Function Decline and Their Association With Clinical Outcomes Within 90 Days After the Initiation of Renal Dialysis. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-01-01 Harvey W Kaufman,Catherine Wang,Yuedong Wang,Hao Han,Sheetal Chaudhuri,Len Usvyat,Carly Hahn Contino,Robert Kossmann,Michael A Kraus
A case study explores patterns of kidney function decline using unsupervised learning methods first and then associating patterns with clinical outcomes using supervised learning methods. Predicting short-term risk of hospitalization and death prior to renal dialysis initiation may help target high-risk patients for more aggressive management. This study combined clinical data from patients presenting
-
Advances in Chronic Kidney Disease Lead Editorial Outlining the Future of Artificial Intelligence/Machine Learning in Nephrology. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2023-01-01 Peter Kotanko,Girish N Nadkarni
-
Advances in Kidney Disease and Health: It's all in the Name. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-12-15 Charuhas V Thakar
-
Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-12-14 Biruh T Workeneh,Priti Meena,Mirjam Christ-Crain,Helbert Rondon-Berrios
Hyponatremia is one of the most common problems encountered in clinical practice and one of the least-understood because accurate diagnosis and management require some familiarity with water homeostasis physiology, making the topic seemingly complex. The prevalence of hyponatremia depends on the nature of the population studied and the criteria used to define it. Hyponatremia is associated with poor
-
Deep Learning for Image Analysis in Kidney Care. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-12-14 Hanjie Zhang,Max Botler,Jeroen P Kooman
Analysis of medical images, such as radiological or tissue specimens, is an indispensable part of medical diagnostics. Conventionally done manually, the process may sometimes be time-consuming and prone to interobserver variability. Image classification and segmentation by deep learning strategies, predominantly convolutional neural networks, may provide a significant advance in the diagnostic process
-
Artificial Intelligence in Pediatric Nephrology-A Call for Action. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-12-13 Guido Filler,Debbie S Gipson,Didier Iyamuremye,Maria Esther Díaz González de Ferris
Artificial intelligence is playing an increasingly important role in many fields of clinical care to assist health care providers in patient management. In adult-focused nephrology, artificial intelligence is beginning to be used to improve clinical care, hemodialysis prescriptions, and follow-up of transplant recipients. This article provides an overview of medical artificial intelligence applications
-
Artificial Intelligence and Machine Learning in Perioperative Acute Kidney Injury. Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-12-08 Kullaya Takkavatakarn,Ira S Hofer
Acute kidney injury (AKI) is a common complication after a surgery, especially in cardiac and aortic procedures, and has a significant impact on morbidity and mortality. Early identification of high-risk patients and providing effective prevention and therapeutic approach are the main strategies for reducing the possibility of perioperative AKI. Consequently, several risk-prediction models and risk
-
Evaluation Evolution: Designing Optimal Evaluations to Enhance Learning in Nephrology Fellowship Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Sana Waheed, Laura Maursetter
Evaluations serve as the backbone of any educational program and can be broadly divided into formative and summative evaluations. Formative evaluations are “just in time” evaluations focused on informing the learning process, whereas summative evaluations compare fellows to a preset standard to determine their readiness for unsupervised practice. In the nephrology fellowship programs, evaluations assess
-
-
-
-
Challenges in Nephrology Education: Integration of the Preclinical Curriculum Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Lauren D. Stern, Karen Warburton, Tonia Kim, Molly Cohen-Osher
Abstract not available
-
What's Old Is New Again: Harnessing the Power of Original Experiments to Learn Renal Physiology Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Melanie P. Hoenig, Stewart H. Lecker, Jeffrey H. William
Although medical schools across the United States have updated their curricula to incorporate active learning techniques, there has been little discussion on the nature of the content presented to students. Here, we share detailed examples of our experience in using original experiments to lay the groundwork for foundational concepts in renal physiology and pathophysiology. We believe that this approach
-
A Framework for Antiracist Curriculum Changes in Nephrology Education Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Paloma Orozco Scott, Jerrel L. Catlett, Carina Seah, Staci Leisman
Addressing persistent racial health disparities in cases of kidney disease will first require significant investment in examining how structural racism has influenced our clinical practice and medical education. Improving how we understand and articulate race is critical for achieving this goal. This work begins with ensuring that race's mention within nephrology literature and curricular materials
-
Engendering a Love of Nephrology Among Medicine Residents: Education Over Recruitment Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Rachel Hilburg, Jordana B. Cohen, Dan Negoianu
Dwindling interest in nephrology amid a growing prevalence of kidney disease has inspired nephrologists to create educational initiatives for trainees. Engagement at all levels is crucial to fostering interest in the field, and experience for internal medicine residents has been a significant area for growth. In this article, we review the literature on available educational programs at the residency
-
Nephrology Education in Private Practice: My Perspective Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Katherine Westin Kwon
Abstract not available
-
Current Trends and Challenges in Nephrology Fellowship Training: Expansion of Education in Home Dialysis, Palliative Care, and Point-of-Care Ultrasound Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Keiko I. Greenberg, Negiin Pourafshar, Michael J. Choi
Nephrology education has changed significantly since the first nephrology fellowship programs were established in the United States in the 1950s and 1960s. The past several years have seen increased opportunities for subspecialization in areas such as interventional nephrology, onconephrology, and glomerular disease. Notable trends in fellowship curricula include the expansion of education in home
-
Clinician Educator Pathway for Nephrology Fellows: The University of North Carolina Experience Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Gargi S. Priamvada, Elizabeth S. Kotzen, Koyal Jain
Nephrologists have a significant role in educating and mentoring trainees. They are considered role models and a major reason for fellows to be attracted to the specialty. Nephrology training programs not only support fellows in their teaching endeavors but also provide them with the necessary knowledge and skills required for advancing their careers as clinician educators. However, such career development
-
Kidney Pathology Education for Nephrology Fellows: Past, Present, and Future Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Michael Kuperman, Shree Sharma, Alejandro Best, Manisha Singh, Tiffany Caza
Kidney pathology education is a critical component in training of nephrology fellows, as well as for continuing medical education for practicing nephrologists. Kidney pathology images are included on nephrology fellow board exams, and clinicopathologic correlation of kidney biopsy findings is critical in everyday clinical practice. Nephropathology training is a requirement by the American College of
-
Postgraduate Education and Training for the Nephrology Physician Assistants and Nurse Practitioners Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Amy Sears, Jane Davis, Kim Zuber
There is no consistent educational model to introduce the physician assistant and/or nurse practitioner to nephrology. The job descriptions of the nephrology physician assistant/nurse practitioner may be similar, but the training, state and federal licensing, background, and recertification are different for the 2 professions adding a level of complexity to the training of the physician assistant/nurse
-
The Physician Leader: Teaching Leadership in Medicine Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-11-09 Amy A. Yau, Priscilla Cortez, Bourne L. Auguste
An integral part of a physician's practice includes being a leader, especially as there is a strong need for skilled leaders to advocate and navigate patient-centered and organizational outcomes. Nephrologists undertake multiple leadership roles, but dedicated leadership training is lacking in medical and postgraduate education. Given the growing need for physician leaders, practitioners in nephrology
-
Nephrology Education: Time for a Change Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-10-19 Staci Leisman, Niralee Patel
Abstract not available
-
The Future of Artificial Intelligence and Machine Learning in Kidney Health and Disease Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-10-14 Girish N. Nadkarni, Peter Kotanko
Abstract not available
-
Practical Implementation and Challenges of Artificial Intelligence-Driven Electronic Health Record Evaluation: Protected Health Information Adv. Kidney Dis. Health (IF 2.9) Pub Date : 2022-10-14 Adam P. Tashman
Detecting protected health information in electronic health record systems is often an early step in health care analytics, and it is a nontrivial problem. Specific challenges include finding clinician names and diseases, which lack a fixed format and are often context-dependent. The general problem of finding entities, termed named-entity recognition, has received a substantial amount of attention
-
-
-